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A primate model of severe 
malarial anaemia: a comparative 
pathogenesis study
Amber i. Raja1, elizabeth B. Brickley1,2, Jessica taaffe1, timmy ton3, Zhen Zhao3,4, 
Kevin W. Bock  5, Sachy orr-Gonzalez1, Marvin L. thomas iii6, Lynn e. Lambert1, 
ian n. Moore5 & patrick e. Duffy  1*
Severe malarial anaemia (SMA) is the most common life-threatening complication of Plasmodium 
falciparum infection in African children. SMA is characterised by haemolysis and inadequate 
erythropoiesis, and is associated with dysregulated inflammatory responses and reduced complement 
regulatory protein levels (including CD35). However, a deeper mechanistic understanding of the 
pathogenesis requires improved animal models. in this comparative study of two closely related 
macaque species, we interrogated potential causal factors for their differential and temporal 
relationships to onset of SMA. We found that rhesus macaques inoculated with blood-stage Plasmodium 
coatneyi developed SMA within 2 weeks, with no other severe outcomes, whereas infected cynomolgus 
macaques experienced only mild/ moderate anaemia. the abrupt drop in haematocrit in rhesus was 
accompanied by consumption of haptoglobin (haemolysis) and poor reticulocyte production. Rhesus 
developed a greater inflammatory response than cynomolgus macaques, and had lower baseline levels 
of CD35 on red blood cells (RBCs) leading to a significant reduction in the proportion of CD35+ RBcs 
during infection. overall, severe anaemia in rhesus macaques infected with P. coatneyi has similar 
features to SMA in children. Our comparisons are consistent with an association of low baseline CD35 
levels on RBCs and of early inflammatory responses with the pathogenesis of SMA.
The burden of malaria is greatest amongst children under the age of 5 years, who suffer 70% of all malaria 
related-deaths and have the highest rates of severe malaria including severe malarial anaemia (SMA)1. SMA is 
defined as a haemoglobin less than 5 g/dL (haematocrit less than 15%) in parasitaemic children and a haemoglo-
bin less than 7 g/dL (haematocrit less than 20%) in parasitaemic adults2. SMA has been estimated to account for 
54% of malaria-related deaths in areas of holoendemic malaria transmission3. Haemolysis and dyserythropoiesis 
are key features of SMA4–9, but the causal haematological and immune mediators of this fatal condition are not 
well defined. Inflammatory cytokine levels in plasma as well as complement regulatory protein levels on red blood 
cells (RBCs) differ between children presenting with SMA versus those with mild malaria [reviewed in10–13], but 
these associations do not confirm causality.
Animal models are essential to interrogate the causation of specific malarial outcomes. Plasmodium coatneyi 
(P. coatneyi) infects non-human primates and has phenotypical similarities to Plasmodium falciparum (P. falci-
parum), with a tertian periodicity (i.e. ~48 hour blood-stage life cycle) and an ability to rosette and sequester in 
deep vascular beds14–20. P. coatneyi can infect several non-human primates, with varying degrees of severity21–23. 
For instance, blood-stage P. coatneyi infection in rhesus and Japanese macaques causes severe malaria, variously 
characterised as cerebral malaria, SMA or multisystem dysfunction14,16,21,22,24,25, whereas in cynomolgus, Southern 
pig-tailed and stump-tailed macaques it causes mild to moderate disease [14,23; reviewed in26].
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Here, we compare rhesus and cynomolgus macaques for their differing susceptibility to develop SMA during 
P. coatneyi blood-stage infection and characterise the anaemia by features such as time of onset, haemolysis, 
and reticulocyte production. We interrogate potential causal factors, including complement regulatory proteins, 
immune activation, and cytokine/ chemokine profiles, for their differential expression in the two models and 
their temporal relationship to the onset of SMA.
Methods
ethics statement. All animal work was approved by the Animal Care and Use Committee at the National 
Institutes of Health under approval LMIV 9E and Animal Assurance number NIH IRP A4149-01. The study was 
carried out under National Institute of Allergy and Infectious Disease (NIAID) Division of Intramural Research 
(DIR) Animal Care and Use Committee guidelines. Parasite inoculations and blood collections on days 0, 4, 7, 
and daily from day 9 onward were carried out under anaesthesia and all efforts were made to minimise the suf-
fering of study animals.
Monkeys. Female rhesus macaques (Macaca mulatta) of Indian origin aged 4 to 6 years old and female cyno-
molgus macaques (Macaca fascicularis) of Vietnamese origin aged 2 to 12 years old were obtained from National 
Institutes of Health breeding colonies. Monkeys were housed in an American Association for the Accreditation of 
Laboratory Animal Care (AAALAC)-approved facility, with a dedicated American College of Laboratory Animal 
Medicine (ACLAM)-accredited staff veterinarian.
Animals were immunised against measles and tested for Mycobacterium tuberculosis exposure quarterly. 
Animal observation was performed at least twice-daily and abnormalities were reported to the veterinarian. 
Standard National Institute of Allergy and Infectious Disease enrichment operating procedures were followed, 
and monkeys were housed in AAALAC-approved cages. A high fibre monkey diet was provided, supplemented 
by fresh fruits, vegetables and nuts, with water ad libitum. Animals were provided with hanging and floor toys, 
with perches in the cages allowing for exercise. The facility was maintained at a temperature between 73°F and 
79°F, a humidity of less than 70%, and a regular light cycle.
Malaria parasite. Blood-stage Plasmodium coatneyi (Hackeri strain) parasites originating from a cry-
opreserved stock from the Centers for Disease Control and Prevention, were blood-passaged once through a 
spleen-intact rhesus macaque, and then stored frozen at a parasitaemia of 7.05% in 0.7 mL aliquots.
Blood-stage P. coatneyi infection and monitoring of disease. Following anaesthesia, four rhesus 
and four cynomolgus macaques were injected intravenously through the saphenous vein with freshly thawed P. 
coatneyi infected RBCs. Each rhesus macaque was paired with a cynomolgus macaque based on weight. Blood 
films for reticulocyte counts were collected starting at baseline and prepared using New Methylene Blue stain 
(Jorgensen Laboratories, Inc.) according to the manufacturer’s instructions. Reticulocyte counts were determined 
by examining a total of 2,000 RBCs, and reticulocyte production indices were calculated as previously described27. 
Following infection, parasitaemia was monitored daily by examining Giemsa-stained thin blood films and cal-
culated using microscopic examination of 2,000 to 10,000 RBCs. Animals were also monitored using complete 
blood counts and differentials and blood chemistries on days 0, 4, 7 and daily from day 9 onward (Fig. 1A).
Paired animals were euthanised using intravenous infusion of B-euthanasia™ (Pentobarbital Sodium) at 
0.2 mL/kg when one animal in the pair reached any of the pre-determined severe malaria criteria (Supplementary 
Table S1), and tissue samples were collected.
Assessment of complement regulatory protein on the surface of RBcs. Blood was collected from 
animals into Lithium-heparin tubes. Two microliters of blood were added to 100 µL of PBS, and an antibody 
mastermix containing anti-CD45 (D058-1283, V500; BD Horizon), anti-CD35 (E11, FITC; Biolegend) and 
anti-CD71 (L01.1, APC; BD Bioscience) was added to each sample. Samples were incubated at 4 °C for 30 min 
and washed three times in PBS by centrifugation at 314 × g for 5 min. The cells were then resuspended in 3 mL 
of PBS, and immediately analysed using the LSR II flow cytometer (BD Biosciences), FACSDiva software version 
8.0.1 (BD Biosciences), and FlowJo software version 10 (FlowJo, LLC). The gating strategy in Supplementary 
Fig. S1 was used to identify markers on RBCs.
Assessment of t cell activation in peripheral blood. Blood was collected into Lithium-heparin tubes. 
An antibody mastermix containing anti-CD3 (SP34- 2, AF700; BD Pharmingen), anti-CD4 (L200, APC-H7; 
BD Pharmingen), anti-CD8 (SK1, PerCP; Biolegend) and anti-CD69 (FN50, PE-Cy7; eBioscience) was added to 
100 µL of blood. Samples were incubated for 30 min at 4 °C, and washed three times in PBS by centrifugation at 
314 × g for 5 min. The cells were resuspended in 400 µL of PBS, and immediately analysed using the LSR II flow 
cytometer (BD Biosciences), FACSDiva software version 8.0.1 (BD Biosciences), and FlowJo software version 10 
(FlowJo, LLC). The gating strategy in Supplementary Fig. S2 was used to identify activated T cells.
Assessment of plasma cytokines and chemokines. Blood was collected into K2 EDTA tubes and cen-
trifuged within 30 min of collection at 1,000 × g for 10 min. The plasma was removed and stored at −80 °C.
Interleukin-1β (IL-1β), IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p40, IL-23, interferon gamma (IFN-γ), tumor 
necrosis factor alpha (TNF-α), monocyte chemoattractant protein 1 (MCP-1), interferon gamma-induced pro-
tein 10 (IP-10), granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte-colony stimulat-
ing factor (G-CSF), macrophage inflammatory protein 1 alpha (MIP-1α), macrophage inflammatory protein 
1 beta (MIP-1β), RANTES, eotaxin, and erythropoietin (EPO) were measured using LEGENDplex custom kits 
(Biolegend) according to the manufacturer’s instructions. Biomarker levels were quantified using LEGENDplexTM 
Data Analysis Software.
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Histology. Following euthanasia, tissue samples collected from various organs were fixed in 10% Neutral 
Buffered Formalin for at least 72 hours before being transferred to 70% ethanol for long-term storage. Processing 
into paraffin blocks, as well as staining with Haematoxylin & Eosin (H&E) and Perls’ Prussian Blue, was per-
formed by Histoserv, Inc. (Germantown, MD). Accumulation of mature parasites in tissue was assessed in H&E 
stained slides, and was evident when numerous small calibre vessels were completely filled with RBCs, at times 
in a Rouleaux-like formation, that consistently contained black pigmented foci, indicating mature parasite stages.
Figure 1. Manifestation of severe malaria during blood-stage P. coatneyi infection in rhesus and cynomolgus 
macaques. (A) The study schedule indicates sample collection timepoints and the number of animals per species 
during the course the infection. (B) Clinical indicators of severe malaria and (C–H) laboratory indicators of 
severe malaria in rhesus (n = 4) and cynomolgus (n = 4) macaques infected with blood-stage P. coatneyi. For 
the graphs in the left panel (C–E) values above the dashed line represent severe malaria and for the graphs in 
the right panel values below the dashed line represent severe malaria. Error bars show the SEM for each group. 
Using linear mixed-effects models the (C) parasitaemias of infected rhesus and cynomolgus macaques were 
compared between days 4 and 11, when all animals remained alive (p = 0.56), and days 12 and 15, when the 
number of animals per group was decreasing (**p < 0.001).
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immunohistochemistry. Formalin-fixed paraffin-embedded sections were cut at 5 µm depth and trans-
ferred to positively-charged microscope slides. Immunohistochemical staining using rabbit polyclonal anti-Iba1 
(Wako Chemicals USA, Inc.) and rabbit polyclonal anti-Myeloperoxidase (Abcam) was carried out on the 
Bond RX (Leica Biosystems) platform according to manufacturer-supplied protocols. Briefly, sections were 
deparaffinised and rehydrated. Heat-induced epitope retrieval (HIER) was performed using Epitope Retrieval 
Solution 1, pH 6.0, heated to 100 °C for 20 min. The primary antibodies were applied at 1:800 (Iba1) and 1:30 
(Myeloperoxidase) dilutions. Detection with Fast Red chromogen was completed using the Bond Polymer Refine 
Red Detection kit (Leica Biosystems #DS9390), a biotin-free polymeric alkaline phosphatase (AP)-linked anti-
body conjugate system. Slides were counterstained with haematoxylin, and then cleared through gradient alcohol 
and xylene washes prior to mounting and coverslipping. All specimens were examined by light microscopy using 
an Olympus BX51 microscope and photomicrographs were taken using an Olympus DP73 camera.
Statistical analysis. Positively skewed continuous variables were log10-transformed before analy-
sis. Prior to infection (i.e. at day 0) and at the time of necropsy, geometric mean biomarker levels were com-
pared cross-sectionally between the rhesus and cynomolgus macaques using an independent two sample 
t-test. After infection (i.e. between days 4 and 11), mean biomarker levels were compared between species 
using linear mixed-effects models that adjusted for linear time trends and day 0 biomarker levels and allowed 
for individual-specific random effects. Parasitaemia levels were also compared between species using linear 
mixed-effects models that adjusted for linear time trends and allowed for individual-specific random effects dur-
ing two time periods: days 4 to 11 post-infection (i.e. when all animals were live) and days 12 to 15 (i.e. when 
the number of animals followed was decreasing). All p-values are from two-sided tests, and all analyses were 
performed using Stata version 15 (StataCorp LP, College Station, TX, USA), R version 3.2.5 or GraphPad Prism 
version 7.
Results
comparative primate models of malarial anaemia. Rhesus and cynomolgus macaques infected with 
blood-stage P. coatneyi were monitored for signs of severe malaria (Supplementary Table S1). These animals did 
not suffer from respiratory distress, prostration or convulsions (Fig. 1B). In addition, neither species suffered 
from hyperparasitaemia (parasitaemia >10%), jaundice (bilirubin >3 mg/dL), renal impairment (creatinine 
>3 mg/dL), hypoglycaemia (glucose <40 mg/dL) or thrombocytopenia (platelets <100 K/µL) (Fig. 1C–E,G,H).
The only severe manifestation of malaria was SMA, which was observed in all four P. coatneyi-infected rhe-
sus macaques, but not in infected cynomolgus macaques (Fig. 1F). Although infected macaques of both spe-
cies exhibited a gradual decline in their haematocrit during infection, rhesus macaques’ haematocrit reached an 
inflection point starting between day 7 and 9. Thereafter, all infected rhesus macaques developed SMA, defined 
as a haematocrit of <20% (as all rhesus macaques were adults), ranging from 17 to 19%, between days 11 and 
15 post-infection. Infected cynomolgus macaques, on the other hand, had a steady and modest decline in their 
haematocrit and did not develop SMA (haematocrit ranged between 24 to 30%) in the 15-day timeframe. In both 
macaque species, P. coatneyi was synchronous, with a tertian periodicity (Fig. 1C) indicating mature stage parasite 
sequestration within deep vascular beds, and prior to day 12, rhesus and cynomolgus macaques supported similar 
parasite densities (p = 0.313).
Deep tissue parasite accumulation and haemozoin deposition. Parasite sequestration or the accu-
mulation of mature parasite forms in deep vascular beds causes microcirculatory obstruction and has been asso-
ciated to severe malaria in adults and children with P. falciparum [reviewed in28]. Parasite sequestration is also 
an established feature of P. coatneyi infection14–16,19,20, with sequestered P. coatneyi infected RBCs proposed to 
cytoadhere to similar endothelial molecules as P. falciparum19,22. Here, we assessed necropsied tissue samples 
from animals who developed SMA and those who did not for differences in parasite accumulation in deep tissue 
vasculature. Necropsies were performed on paired animals simultaneously when one animal in the pair devel-
oped SMA. The pattern of parasite accumulation in deep vascular beds was similar between both species and did 
not appear to be associated with any inflammation or tissue damage in either group. The heart was a major site of 
parasite accumulation in infected rhesus macaques (4 of the 4 rhesus macaques) versus only one of the cynomo-
lgus macaques (Fig. 2A). Mature parasites accumulated within the lumen of small capillaries in the musculature 
of the right and left ventricles, primarily in the microvasculature. We did not appreciate the same phenomenon in 
the coronary arteries nor in the great vessels. The heart has also been shown to be a major site of parasite seques-
tration in children with severe malaria including SMA29, in addition to the intestinal tract. However, in our study 
this may have been due to the higher parasite burden in animals with parasite accumulations in the heart, as all of 
them (including the one cynomolgus macaque) had parasitaemias above 2.3% the day before necropsy whereas 
animals without had parasitaemias of less than 1% the day prior to necropsy.
Organs were also assessed for the presence of parasite pigment (haemozoin). The spleen (Fig. 2C,D) and liver 
were common sites where haemozoin pigment was abundant in both infected species (Fig. 2B). The kidney and 
lung, and the brain to a lesser degree (3 of 4 animals), were also the major sites of haemozoin deposition in rhesus 
macaques (4 of 4 animals), and to a lesser extent in the cynomolgus macaques (1 of 4 animals). However, when 
detected in animal organs, the amount of haemozoin pigment was fairly similar between species. The vast major-
ity of haemozoin in the spleen was within the cytoplasm of macrophages (Fig. 2E,F) and minimally associated 
with neutrophils (Fig. 2G,H) in both species. As the amount of pigment in the spleens of animals in both species 
appeared to be similar, we speculate that the haemolytic differences between the two models were not due to 
extravascular haemolysis of infected RBCs. Future studies can further evaluate this hypothesis by assessing spleen 
size and pigment quantification in greater detail.
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Figure 2. Deep tissue parasite accumulation and haemozoin deposition patterns of P. coatneyi in infected 
rhesus and cynomolgus macaques. (A) Mature parasite accumulation and (B) deposition of parasite pigment 
was assessed using H&E staining of organs from infected rhesus and cynomolgus macaques. H&E stained 
spleens from one representative (C) rhesus and (D) cynomolgus macaque. IBA1 stained spleens from one 
representative (E) rhesus and (F) cynomolgus macaque to assess whether parasite pigment was within the 
cytoplasm of macrophages. Myeloperoxidase stained spleens from one representative (G) rhesus and (H) 
cynomolgus macaque to assess association of parasite pigment and neutrophils. Arrowheads indicate areas 
of haemozoin pigment. Images (C) and (D) were taken at 4X magnification (scale bars represent 200 µm), 
(E) and (G) were taken at 40X magnification (scale bars represent 20 µm), and (F) and (H) were taken at 20X 
magnification (scale bars represent 50 µm).
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The bone marrow was assessed in 2 animals from both species that yielded adequate samples. Perls’ Prussian 
Blue stain was used to differentiate haemosiderin iron storage from haemozoin in the bone marrow of infected 
animals. Although there was no evidence of parasite accumulation in the bone marrow of either species, 
haemozoin was observed in the bone marrow of both infected rhesus macaques, but only in one of the two 
cynomolgus macaques whose bone marrows were assessed (Supplementary Table S2). Bone marrow haemozoin 
deposition is also observed in children with SMA30, but due to the limited number of animals in our study this 
evaluation would need to be repeated with more animals to confirm its significance.
features differentiating models of moderate and severe malarial anaemia. Prior to infec-
tion with P. coatneyi, both macaque species had largely comparable haematological and iron parameters 
(Supplementary Table S3). Of note, haptoglobin levels at baseline were, on average, 29 mg/dL (95% CI: 5, 53) 
lower in the rhesus macaques compared to the cynomolgus macaques, but as an acute phase protein increased to 
similar levels (118.9 mg/dL vs 119.9 mg/dL, respectively) at their peak on day 9.
Rhesus macaques infected with blood-stage P. coatneyi met criteria for SMA between 11 and 15 days 
post-infection (Fig. 1F). At the time of SMA in rhesus macaques, the haematocrit (p = 0.0025), haptoglobin 
(p = 0.0006) and RPI (p = 0.03) were significantly higher in cynomolgus compared to rhesus (Supplementary 
Table S3). To identify factors that may contribute to the development of SMA in rhesus macaques and discrim-
inate them from those related to moderate anaemia in infected cynomolgus macaques, we compared factors 
between the two infected species prior to the majority of rhesus macaques suffering the SMA outcome (days 0 to 
11 post-infection).
Increased destruction of RBCs (infected and uninfected) is characteristic of malarial anaemia7,8, thus 
we assessed haemolysis in both infected species. The consumption of haptoglobin, a glycoprotein that binds 
with high affinity to free haemoglobin, can be used to measure intravascular and extravascular haemolysis31. 
When free haemoglobin is present in the plasma, haptoglobin binds rapidly with it forming a complex that is 
removed by monocytes/ macrophages, resulting in decreased plasma haptoglobin levels [reviewed in32,33]. 
Hypohaptoglobinaemia has been associated with malarial anaemia in African children34, and specifically asso-
ciated with SMA compared to cases of uncomplicated, mild or cerebral malaria35,36. In our SMA model, infected 
rhesus macaques had lower levels of plasma haptoglobin compared to infected cynomolgus macaques on days 
10 (50.5 ± 14.56 vs 114.6 ± 18.09 mg/dL; p = 0.03) and 11 (40.72 ± 13.1 mg/dL vs 98.95 ± 9.431 mg/dL; p = 0.01) 
post-infection (Fig. 3A). The decline in plasma concentrations of haptoglobin in infected rhesus macaques coin-
cided with the drop in haematocrit, whereas infected cynomolgus macaques did not have a comparable decline 
in their haptoglobin levels. At euthanasia, haptoglobin levels in cynomolgus ranged from 48.8 mg/dL to 93.3 mg/
dL whereas in rhesus were < 10 mg/dL to 14.9 mg/dL (p = 0.0006). This suggests that infected rhesus experience 
exacerbated haemolysis compared to infected cynomolgus macaques, which likely contributes to their severe 
outcome.
An inappropriately low erythropoietic response is also a key feature of SMA in children. This can be meas-
ured by the reticulocyte production index (RPI), which corrects the reticulocyte count for the level of anaemia 
and thus indicates whether the bone marrow is adequately compensating for the degree of anaemia36. An RPI 
of >3 is indicative of an appropriate bone marrow response to anaemia, whereas an RPI <2 is indicative of a 
suppressed erythropoietic response [37; reviewed in38]. In holoendemic regions, a low RPI is characteristic of 
malarial anaemia, particularly SMA37,39. The mean RPI of both macaque species remained below 2 throughout 
the infection indicating an inadequate bone marrow response to anaemia (Fig. 3B). However, the RPI of cyno-
molgus macaques was significantly higher than rhesus macaques (p = 0.002; Fig. 3B), with 3 of the 4 cynomolgus 
macaques having RPI values above 2 during the course of infection, whereas the RPI values of all 4 infected rhesus 
macaques remained below 2 throughout infection. Thus, rhesus macaques appeared to display a greater defect in 
erythropoiesis during infection and specifically failed to mount an appropriate erythropoietic response to severe 
anaemia. To determine whether this inadequate erythropoietic response was due to a deficiency in erythropoietin 
(EPO), we quantified plasma EPO levels and found that levels were significantly higher in rhesus macaques com-
pared to cynomolgus macaques during infection (p = 0.007; Fig. 3C). Thus, despite higher levels of EPO rhesus 
macaques failed to mount appropriate reticulocyte responses, as has also been seen in the children with SMA40,41. 
Our results, as well as results from others25, suggest that EPO production is not a contributing factor to the inad-
equate erythropoietic response seen in this model.
immunopathogenesis of severe malarial anaemia. We examined levels of immunological markers 
at baseline and throughout the course of infection that might contribute to disease sequelae. Prior to infection, 
both macaque species had largely comparable immunological parameters (Supplementary Table S4) with a few 
exceptions. Of note, the geometric mean of the median fluorescence intensity (MFI) of CD35 at baseline was, on 
average, 1563 MFI (95% CI: 393, 2732) lower in the rhesus macaques compared to the cynomolgus macaques. 
Interleukin (IL)-1β levels were below the limit of detection for all cynomolgus macaques, whereas levels were 
detectable in three of the four rhesus macaques prior to infection. At the time of SMA in rhesus macaques, CD35 
expression on RBCs (p = 0.0005), MIP-1α (p = 0.005), IL-23 (p = 0.03), MCP-1 (p = 0.02) and TNF-α:IL-10 ratio 
was significantly different between the two infected species (Supplementary Table S4).
Complement is a component of the innate immune response, and is activated during malaria infection42. 
Complement deposition marks cells for phagocytic destruction and removal by the reticuloendothelial system, 
while surface complement regulatory proteins protect from complement attack and lysis. Lower levels of comple-
ment regulatory proteins, such as CD35, on the surface of RBCs have been observed in children with SMA11–13. As 
noted above, CD35 expression on RBCs was markedly different at baseline between our two models of malarial 
anaemia (p = 0.01; Supplementary Table S4 & Fig. 4A). However, when normalised to baseline, the proportional 
loss of CD35 on RBCs during the course of infection did not discriminate the two models (p = 0.496; Fig. 4B). 
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Instead, owing to their low baseline CD35 levels, the overall reduction in the percentage of CD35+ RBCs was 
significant in infected rhesus (59.7 ± 15.8% reduction by day 11; p = 0.014) compared to infected cynomolgus 
macaques (4.8 ± 2.8% reduction) (Fig. 4C). The percentage of reticulocytes (CD71+ RBCs) that were CD35+ 
remained consistent throughout infection in both species (Fig. 4D), indicating that there was no alteration of 
CD35+ immature RBCs produced by the bone marrow during SMA in rhesus macaques, and that the loss of 
CD35 occurred in circulating normocytes.
The severity of clinical disease experienced by Plasmodium infected individuals can be influenced by the 
ability to regulate and control their immune responses [reviewed in43]. Cytokines and chemokines have a key role 
in maintaining a balanced response to infection. While an early and robust inflammatory response is critical for 
controlling acute blood-stage infection, uncontrolled inflammation might contribute to severe malaria patho-
genesis including SMA44–46. Plasma cytokine and chemokine profiles were assessed in both rhesus and cyno-
molgus macaques infected with blood-stage P. coatneyi. A total of 18 cytokines and chemokines were assessed 
(full list provided in the Methods) based on previous reports on their relevance to anaemia and SMA [reviewed 
in10]. Baseline levels of cytokines and chemokines did not differ significantly between species, other than IL-1β 
which was elevated in the rhesus macaques. During infection (days 4–11), six cytokines and chemokines (IP-
10, MIP-1α, IL-23, GM-CSF, TNF-α and TNF-α: IL-10 ratio) differed significantly between rhesus who suf-
fered SMA and cynomolgus who did not (Fig. 5A–H & Supplementary Table S5). IP-10 (p = 0.015), MIP-1α 
(p = 0.004), GM-CSF (p = 0.025), IL-23 (p < 0.001), TNF-α (p < 0.001) and TNF-α: IL-10 ratio (p < 0.001) were 
significantly higher in the plasma of infected rhesus macaques after adjustment for baseline values. Interleukin-23 
was significantly higher in rhesus macaques than in cynomolgus macaques, but this difference appeared to be due 
in part to decreased levels during infection in the plasma of cynomolgus macaques (Fig. 5D).
T cells have been implicated in the pathogenesis of SMA47,48. Thus, we assessed the immune activation of 
CD4+ and CD8+ T cells during development of SMA, using a marker of early activation (CD69). There was no 
significant difference in early activation of CD8+ T cells (p = 0.360; Fig. 6B). Although not significantly different, 
rhesus macaques had a distinct elevation in their activated CD4 T cells at day 9 post-infection (p = 0.174; Fig. 6A) 
and approached significance at the time of SMA in rhesus macaques (p = 0.08; Supplementary Table S4).
Figure 3. Haematological indicators during early blood-stage P. coatneyi infection. (A) Haptoglobin, (B) 
reticulocyte production index and (C) erythropoietin levels in rhesus (n = 4) and cynomolgus (n = 4) macaques 
infected with blood-stage P. coatneyi parasites. Error bars show SEM for each group. Haptoglobin data were 
analysed using an unpaired, two-tailed t-test, with *indicating p values < 0.05. Reticulocyte production index 
and log10 erythropoietin were compared between species on days 4 to 11 using linear mixed-effects models that 
adjusted for linear time trends and day 0 levels, and allowed for individual-specific random effects.
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Discussion
Blood-stage P. coatneyi infection in rhesus macaques has previously been described as a relevant model of P. falci-
parum infection in humans, due to its tertian periodicity, and its ability to sequester and to cause severe malaria in 
these animals15,19,20,22. Here, we described the characteristic features of severe malaria anaemia (SMA) using two 
closely related macaques and found that these closely paralleled features that have previously been described in 
African children with SMA. We further interrogated the differential expression and temporal patterns of factors 
previously implicated in SMA in human studies, to support their causal roles in the pathogenesis of SMA using 
rhesus versus cynomolgus macaques.
In previous P. coatneyi infection studies, parameters of malaria-infected animals have been compared to those 
of uninfected control animals19,25,49. In the current study, we compared the parameters and outcomes of P. coatneyi 
blood-stage infection in two closely related host species50, the rhesus and cynomolgus macaque, to discriminate 
pathogenic factors that associate with susceptibility and that appear before the outcome of SMA. Many of the ini-
tial studies of blood-stage P. coatneyi infection in rhesus macaques suggested it may be a model to study cerebral 
malaria16,22,24 and multi-organ dysfunction;25 however in the current study, blood-stage P. coatneyi infection in 
female rhesus and cynomolgus did not cause convulsions, prostration, hyperparasitaemia, jaundice, renal impair-
ment, hypoglycaemia or thrombocytopenia. The single severe outcome of SMA (haematocrit <20%) occurred 
in P. coatneyi-infected rhesus macaques but not cynomolgus macaques. Studies in children have demonstrated 
that severe malaria most commonly presents as a single condition, such as convulsions or severe anaemia51–53. 
Additionally, in our studies to date, including this report, SMA has been a consistent feature of blood-stage P. 
coatneyi infection in rhesus macaques irrespective of their ages, which have ranged from 4–12 years old. It should 
be noted that in the earlier animal studies many of the animals had hyperparasitaemia (parasitaemia >10%)16,22,24, 
unlike the current study, thus that higher parasite burden may have contributed to the development of cere-
bral malaria. Other differences seen between the current study and those previously reported (some also using 
Hackeri strain of P. coatneyi) may be due to differences in factors such as geographic origin and genotype of the 
rhesus, or diet and other environmental factors.
In the approximately 2-week timeframe of observation in the current study, infected cynomolgus macaques 
developed mild to moderate anaemia. However, we cannot exclude that cynomolgus macaques may have devel-
oped SMA if monitored over a longer period, as has been seen in some but not all infected cynomolgus in a 
previous report54.
One key parameter distinguishing our models of SMA and moderate anaemia was rapid haemolysis, as 
assessed by an accelerated drop in plasma haptoglobin levels in infected rhesus compared to infected cynomolgus 
macaques. This drop in haptoglobin occurred at the inflection point of a decline in haematocrit in infected rhesus 
macaques. In a field setting; however, plasma haptoglobin cannot be used to determine the severity of haemolysis, 
due to its rapid and often complete consumption during episodes of haemolysis55. Haemopexin determinations 
Figure 4. Complement regulatory protein (CD35) on RBCs during the early course of P. coatneyi blood-stage 
infection. Blood samples were collected and assessed during blood-stage P. coatneyi infection in rhesus (n = 4) 
and cynomolgus (n = 4) macaques for (A) the median fluorescence intensity (MFI) of RBCs, (B) the MFI 
normalised to the baseline of each animal, (C) the percentage of CD35+ RBCs normalised to the baseline of 
each animal and (D) the percentage of CD35+ reticulocytes (CD71+). Error bars show SEM for each group. 
Data in graph (C) were analysed using an unpaired, two-tailed t-test, with *indicating p values < 0.05.
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Figure 5. Cytokine and chemokine response during early blood-stage P. coatneyi infection in rhesus and 
cynomolgus macaques. Plasma samples were collected from rhesus and cynomolgus macaques on day 0, 4, 7, 
9 and 11 post blood-stage P. coatneyi infection and were assessed for (A) MIP-1α, (B) IP-10, (C) GM-CSF, (D) 
IL-23, (E) TNFα and (F) TNFα: IL-10 ratio levels. Error bars show SEM for each group. Log10 biomarker levels 
were compared between species on days 4 to 11 using linear mixed-effects models that adjusted for linear time 
trends and day 0 levels, and allowed for individual-specific random effects.
Figure 6. Immune activation of CD4 and CD8 T cells during early blood-stage P. coatneyi infection in rhesus 
and cynomolgus macaques. Blood samples were collected from rhesus and cynomolgus macaques on day 0, 4, 
7, 9 and 11 post blood-stage P. coatneyi infection. The percentage of (A) CD4 and (B) CD8 T cells expressing 
CD69. Error bars show SEM for each group.
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are recommended to judge the severity of haemolysis in the absence of haptoglobin55. We were unable to deter-
mine whether the haemolysis was largely intravascular or extravascular. However, using bilirubin as the marker of 
extravascular haemolysis, as has previously been described [reviewed in56], there was no difference in this marker 
between the two species, suggesting that there were differences in intravascular rather than extravascular haemol-
ysis in the two models. Using parasite pigment deposition in the spleen as a crude measurement of extravascular 
haemolysis of infected RBCs showed no difference in the presence of haemozoin, suggesting that there was no 
difference between the clearance of infected RBCs between the two models. In addition, the parasite burden 
from day 0 to 11 post-infection was comparable between the two models. Taken together these data indicate 
that there is likely to be accelerated clearance of uninfected RBCs in animals who suffer SMA compared to those 
that do not. Moreno et al.25 demonstrated that there was accelerated clearance of biotinylated RBCs in rhesus 
macaques infected with blood-stage P. coatneyi. Similar to our study, they also observed an acute drop in haemat-
ocrit that occurred at relatively low parasitaemia, which suggests the destruction of uninfected as well as infected 
RBCs25, similar to humans in whom the vast majority (approximately 90%) of cleared RBCs are uninfected7,8. The 
basis for this is not established, although RBC deformability is reduced during malaria infection, affecting both 
infected57,58 and uninfected RBCs59,60, and this is positively associated with the degree of anaemia60. Further, it 
has been suggested7 that during acute malaria there is a reduced splenic threshold for rigid61 and antibody-coated 
RBCs62,63 leading to removal of RBCs.
In Gambian children, the sequestered parasitic biomass, measured by plasma levels of the secreted parasite 
protein HRP2, was higher in patients with SMA than uncomplicated malaria64. Here, we assessed parasite burden 
within specific organs and found that mature parasite accumulations within cardiac microvessels was a consistent 
feature of rhesus who had developed SMA. However, in this small study, this phenomenon could not be dissoci-
ated from higher peripheral blood parasite density the day prior to tissue sampling.
Both macaque species supported similar peripheral parasite densities prior to day 12 post-infection, at which 
point differences in parasitaemia were observed and may have contributed to differences in RBC loss between 
the two infected species. However, the different trajectories of declining haematocrit in the two species appeared 
prior to day 12 and before differences in the parasitaemia occurred. Furthermore, the cumulative loss of RBCs 
exceeded the cumulative level of infected red cells during infection. This suggests that other factors are involved 
earlier in infection and may contribute to the development of SMA.
Complement regulatory proteins, such as CD35, on the surface of cells protect from attack and lytic effects 
of complement. CD35 binds to immune complexes, and both can be removed from the RBC surface by mac-
rophages during passage through the reticuloendothelial system65. This can leave the RBC vulnerable to com-
plement attack and haemolysis. Levels of CD35, and other complement regulatory proteins, such as CD55 and 
CD59, are lower on the surface of RBCs in patients with SMA11–13. RBCs from these patients also have increased 
susceptibility to phagocytosis versus those from patients with uncomplicated malaria13. While CD35 is expressed 
as the full-length protein on human RBCs, smaller as well as full length versions of CD35 are expressed on RBCs 
from non-human primates [reviewed in66]. Our assessment of CD35 levels on RBCs by flow cytometry revealed 
that at baseline levels were substantially lower in rhesus than cynomolgus macaques, and we hypothesise that this 
could be integral to the susceptibility of these rhesus macaques to develop SMA. Of note, early flow cytometry 
experiments showed that the E11 clone used in our study bound to CD35 on the surface of RBCs from both 
rhesus and cynomolgus macaques to a similar degree67. The differences between our RBC surface reactivity data 
for rhesus and those from the previous study may reflect a difference in the origins of the macaques. Rhesus 
macaques inhabit a wide geographical area68, which may have allowed for genotypical differences69, and possible 
differences in CD35 expression patterns on RBCs.
We hypothesise that baseline differences in CD35 levels between children at the time of infection might influ-
ence their susceptibility to SMA; studies have assessed expression of complement regulatory proteins at SMA 
diagnosis and after treatment11,13, but not at baseline. After blood transfusion and treatment with anti-malarial 
drugs for SMA, CD35 recovers to levels comparable to those in children treated for uncomplicated malaria11,13, 
but a potential transient correction due to the presence of transfused RBCs cannot be excluded13. Here, the pro-
portional loss of CD35 on RBCs was comparable between the two models, but this led to a significant reduction 
of CD35+ RBCs only in rhesus, which notably had lower baseline CD35 surface levels. Our assessment of CD35 
entailed flow cytometry analysis of RBCs after antibody labelling of surface antigens; protein assessment by west-
ern blot or mass spectrometry in future studies may reveal further information about protein abundance and 
variants.
A study of Gabonese children demonstrated an inverse relationship between haematocrit and plasma EPO40. 
As haematocrit decreased, EPO levels increased exponentially40. Thus, it is not a reduction in EPO production 
that contributes to the pathogenesis of malarial anaemia40. Similar to these findings in children, and as has pre-
viously been shown25, rhesus macaques infected with P. coatneyi produce EPO in response to the acute anaemia 
and it is not the absence of EPO that contributes to the inappropriate reticulocyte production in this model25. 
Although erythropoiesis was stimulated (i.e. as indicated by production of EPO) in animals who developed SMA, 
these animals failed to produce an appropriate reticulocyte response. If there is a block in maturation or release of 
RBCs, intensive EPO stimulation could lead to accumulation of immature RBCs in the bone marrow41. A study of 
Ghanaian children demonstrated that EPO is increased during SMA to induce erythropoiesis but that maturation 
or release of reticulocytes is limited/ blocked until after the clearance of parasites41. The cause of this reversible 
suppression of erythropoiesis may be morphological changes in the bone marrow4,6,70,71, a direct inhibitory or 
blockage effect of the parasites71, inflammatory mediators72 or haemozoin pigment30,73. Although our study only 
assessed a limited number of bone marrow samples from infected animals and needs to be repeated, haemozoin 
was more frequently observed in the bone marrow of rhesus macaques. The presence of haemozoin has been 
shown to suppress erythropoiesis and to associate with an inflammatory response in vitro30,74.
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Assessment of peripheral cytokine and chemokine levels demonstrated a more robust pro-inflammatory pro-
file in infected rhesus macaques than cynomolgus macaques, which may contribute to the outcome of SMA in 
rhesus macaques. Many studies from malaria endemic countries demonstrated an association of a high TNF-α 
and IL-10 plasma ratios in young children presenting with SMA44,46,75, which was also a distinguishing factor 
between our models of severe and moderate anaemia. Our data suggest that higher levels of TNF- α between 
days 4 and 11 post-infection were responsible for this imbalance, whereas a number of field studies attribute this 
imbalance to lower levels of IL-10 in SMA rather than an increase in TNF-α46,75. In either case, SMA was associ-
ated to a dysregulated inflammatory response. IL-23 was also a distinguishing factor of our models of moderate 
and severe anaemia; however, a study in Kenyan children showed IL-23 was elevated in children with malarial 
anaemia, but did not differentiate children with SMA and those with mild malarial anaemia76. At the time of SMA 
in rhesus macaques, GM-CSF and IP-10 did not discriminate SMA from moderate anaemia, as has been reported 
in children presenting at hospital with SMA77. However, our assessment during the course of infection high-
lighted that higher levels of GM-CSF and IP-10, as well as MIP-1α, in rhesus may be important in the develop-
ment of SMA. GM-CSF is known to promote erythropoiesis [reviewed in78] and in P. falciparum infection it can 
synergise with TNF-α to increase the anti-parasitic activity of neutrophils during blood-stage infection79. Plasma 
levels of IP-10 have been associated to cerebral malaria80 and increased levels of MIP-1α have been observed in 
children with severe malaria81, but no such associations has been made specifically with SMA. Our data suggest 
that activation of CD8+ T cells, as assessed by CD69, does not play a role in the development of SMA during acute 
infection, with the caveat that peripheral blood measurements may not reflect changes occurring within tissue. 
Although not statistically significant, an increase in activated CD4+ T cells in rhesus macaques coincided with 
the drops in haematocrit and haptoglobin levels. Thus, the role of CD4+ T cells in the development of SMA may 
still be important. Additionally, activation of innate immune cells, such as monocytes and neutrophils, may have 
a more important role during acute malaria82–85.
This study adds to the accumulating body of evidence25,86 that blood-stage P. coatneyi infection in rhesus 
macaques is a relevant and valuable model for investigating SMA, and supports the causal role for several factors 
previously associated with SMA in children. P. coatneyi infected rhesus macaques suffer SMA with rapid onset 
and features including haemolysis and inadequate reticulocyte production, similar to children. As in children, 
increased EPO expression had no clear impact on reticulocyte levels in the blood of rhesus macaques. Increased 
pro-inflammatory cytokine responses [reviewed in10] and low levels of CD35 on RBCs11–13 have been seen in chil-
dren at the time of SMA. Our data showing increased pro-inflammatory responses during early infection and low 
levels of CD35 on RBCs at baseline are consistent with the idea that these have causal roles in the pathogenesis of 
SMA. The findings from this study highlight the relevance of P. coatneyi blood-stage infection in rhesus macaques 
as a suitable model to further investigate SMA. Future studies of interventions that modulate host inflamma-
tory responses or CD35 levels on RBCs in P. coatneyi infected rhesus macaques may identify new therapeutic 
approaches for SMA.
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